Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.35 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17960733 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TSHRNPSR1GLO1CYP3A4 | |
| SCHEMBL94679 | 0.82 | ALDH1A1 (0.54) | ALDH1A1TSHRNPSR1GLO1MAPT | |
| SCHEMBL21880057 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TSHRCYP3A4MAPTSMN1; SMN2 | |
| SCHEMBL4725132 | 0.80 | ALDH1A1 (0.41) | ALDH1A1TSHRNPSR1GLO1MAPT | |
| Hydrochloric Acid SCHEMBL27667582 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRNPSR1GLO1MAPT | |
| SCHEMBL29067277 | 0.79 | TSHR (0.40) | ALDH1A1TSHRNPSR1GLO1CYP3A4 | |
| SCHEMBL352128 | 0.78 | TSHR (0.47) | ALDH1A1TSHRCYP3A4MAPTTDP1 | |
| SCHEMBL27545604 | 0.77 | TSHR (0.46) | ALDH1A1TSHRNPSR1GLO1CYP3A4 | |
| SCHEMBL4001053 | 0.77 | ALDH1A1 (0.45) | ALDH1A1TSHRNPSR1GLO1MAPT | |
| SCHEMBL6274691 | 0.76 | TSHR (0.53) | ALDH1A1TSHRNPSR1CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114836159-A | Adhesive composition and application thereof | 长沙汇意圆科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-112292100-A | Composition with high reaction index and high dispersion coefficient | 强生外科视力公司 | 2021-01-29 | — | — | CN | claimed |
| CN-112034644-A | Gel-stabilized liquid crystal writing board film and preparation method thereof | 南京优写智能科技有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-111983844-A | Polymer dispersed liquid crystal film based on liquid crystal physical gel and preparation method thereof | 南京优写智能科技有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-110998291-B | Colorimetric sensor and method for manufacturing same | 德林克萨维有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-114836159-A | Adhesive composition and application thereof | 长沙汇意圆科技有限公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-112292100-A | Composition with high reaction index and high dispersion coefficient | 强生外科视力公司 | 2021-01-29 | — | — | CN | disclosed |
| CN-112034644-A | Gel-stabilized liquid crystal writing board film and preparation method thereof | 南京优写智能科技有限公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-111983844-A | Polymer dispersed liquid crystal film based on liquid crystal physical gel and preparation method thereof | 南京优写智能科技有限公司 | 2020-11-24 | — | — | CN | disclosed |
| CN-111675809-A | Holographic photopolymer material based on two-stage mercapto-alkene polymerization reaction | 长江师范学院 | 2020-09-18 | — | — | CN | disclosed |
| CN-110998291-A | Colorimetric sensor and method for manufacturing same | 德林克萨维有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-106715495-A | Allyl acrylate crosslinkers for PSAs | 3M创新有限公司 | 2017-05-24 | — | — | CN | disclosed |
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MERCK SHARP & DOHME LLC | 2009-05-07 | — | — | US | disclosed |
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MERCK SHARP & DOHME LLC | 2009-05-07 | — | — | US | disclosed |
| EP-1966151-A1 | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | SCHERING CORPORATION (US) | 2008-09-10 | — | — | EP | disclosed |
| US-20080171272-A1 | CURABLE COMPOSITION, COLOR FILTER USING THE SAME AND MANUFACTUIRNG METHOD THEREFOR, AND SOLID IMAGE PICKUP ELEMENT | FUJIFILM CORPORATION (JP) | 2008-07-17 | — | — | US | disclosed |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | SCHERING CORPORATION | 2007-08-16 | — | — | US | disclosed |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | SCHERING CORPORATION | 2007-08-16 | — | — | US | disclosed |
| WO-2007070398-A1 | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | SCHERING CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| WO-2007070398-A1 | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | SCHERING CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MAPK1, MAPK4, MAPK10 | ALDH1A1 277/4885TSHR 3596/4885NPSR1 3152/4885 |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | MAPK1, MAPK4, MAPKAPK2 | ALDH1A1 342/4885TSHR 3724/4885NPSR1 3054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.